DER develops, implements, and coordinates cross-cutting, multidisciplinary research activities within NICHD's mission. The research portfolio is quite broad, including biological, behavioral, and clinical research related to conception and pregnancy, normal and abnormal development in childhood, reproductive health, and population dynamics across the lifespan. While NICHD's Division of Intramural Research conducts laboratory and clinical research programs at NIH, DER coordinates and funds research and training programs across the United States and many other countries through grants and contracts.
DER advises the NICHD Director on extramural research and training policies and activities. It also provides scientific peer review, grants management, and program management and oversight for roughly 3,500 competing grant applications and over 450 new and competing awards each year. With a focus on scientific priorities and research integrity, DER leads implementation of extramural policies and procedures for NICHD.
Safe Return to School For All summarizes current evidence and best practices to help administrators, educators, and families and students—including students with disabilities—return to school safely in the context of COVID-19. The information provided is based on collaborative research from the NICHD-funded Washington University Intellectual and Developmental Disabilities Research Center, the University of Missouri-Kansas City Institute of Human Development, and the Kennedy Krieger Institute (Maryland), in collaboration with the Special School District of St. Louis County, Missouri.
- Active Funding Opportunity Announcements
- PA-18-480: NICHD Research Project Grant (R01 – Clinical Trial Required)
Supports clinical trials; the new parent R01 FOA will not allow clinical trials.
- PA-18-481: NICHD Small Grant Program (R03 – Clinical Trial Optional)
Supports both clinical trials and non-trial research; the new parent R03 FOA will not allow clinical trials.
- PA-18-482: NICHD Exploratory/Developmental Research Grant (R21 – Clinical Trial Optional)
Supports both clinical trials and non-trial research; the new parent R21 FOA will not allow clinical trials. Please note that NICHD no longer participates in the parent R21 FOA. NICHD will not accept applications submitted to the parent R21 FOA.
- PA-18-343: Academic Research Enhancement Award (R15 – Clinical Trial Required)
Joint FOA with NIDCD, NIBIB, and NIMH; the new parent R15 FOA will not allow clinical trials.